SNSE — Sensei Biotherapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $16.78m
- -$39.86m
- 35
- 53
- 49
- 42
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.251 | 16.6 | 148 | 107 | 65.8 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.502 | 20.1 | 149 | 109 | 67.3 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.268 | 1.27 | 4.64 | 9.72 | 7.04 |
Other Long Term Assets | |||||
Total Assets | 1.22 | 21.4 | 153 | 118 | 74.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 21.7 | 4.83 | 4.89 | 9.07 | 5.64 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 22.3 | 5.54 | 6.71 | 15 | 9.48 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -21.1 | 15.9 | 147 | 103 | 64.9 |
Total Liabilities & Shareholders' Equity | 1.22 | 21.4 | 153 | 118 | 74.4 |
Total Common Shares Outstanding |